While COVID-19 will likely take a bite out of 2020 plans for Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN), Raymond James … [Read more...] about Profound Medical has price target cut at Raymond James
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Following the company's fourth quarter results, Stifel Canada analyst Justin Keywood has chopped his price target on Cipher Pharma (Cipher Pharma … [Read more...] about Cipher Pharma has price target cut at Stifel Canada
Its chart is one of the rare ones that doesn't look like a black diamond ski run, by analyst André Uddin says you can still make money off BELLUS … [Read more...] about BELLUS Health has more upside left, Mackie Research says
Following the company's fourth quarter results, Stifel Canada analyst Justin Keywood has maintained his "Buy" rating on HLS Therapeutics (HLS … [Read more...] about Buy HLS Therapeutics for a double, Stifel Canada says
There’s no change in analyst Douglas Loe’s valuation or development timelines for clinical-stage biotech name IMV (IMV Stock Quote, Chart, News … [Read more...] about A COVID-19 vaccine? Canada’s IMV might have the technology
Mackie Research analyst André Uddin is holding steady with Bellus Health (Bellus Health Stock Quote, Chart, News TSX:BLU) after clinical trial news … [Read more...] about Bellus Health is a double from here, says Mackie Research
In a note to clients on Monday, Mackie Research analyst André Uddin changed his rating on Correvio Pharma (Correvio Pharma Stock Quote, Chart, News … [Read more...] about Correvio Pharma shareholders should take the Advanz offer: Mackie
New clinical results from biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) signal a less straightforward path to commercialization than … [Read more...] about IMV gets price target cut from Raymond James
Is Pfizer (Pfizer Stock Quote, Chart, News NYSE:PFE) looking interesting here? With its gains over the past couple of years effectively erased now and … [Read more...] about Is it time to sell your Pfizer stock?
After reporting fourth quarter earnings, GW Pharmaceuticals (GW Pharmaceuticals Stock Quote, Chart, News NASDAQ:GWPH) has received a target reduction … [Read more...] about GW Pharmaceuticals keeps “Outperform” rating at AltaCorp Capital